These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28029542)

  • 1. Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
    Ramezanpour B; Haan I; Osterhaus A; Claassen E
    Vaccine; 2016 Dec; 34(50):6436-6448. PubMed ID: 28029542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poxviruses as vaccine vectors.
    Pastoret PP; Vanderplasschen A
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
    Verardi PH; Titong A; Hagen CJ
    Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New viral vectors for infectious diseases and cancer.
    Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
    Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune recognition of poxviral vaccine vectors.
    Lousberg EL; Diener KR; Brown MP; Hayball JD
    Expert Rev Vaccines; 2011 Oct; 10(10):1435-49. PubMed ID: 21988308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery.
    Sutter G; Staib C
    Curr Drug Targets Infect Disord; 2003 Sep; 3(3):263-71. PubMed ID: 14529359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.
    Volz A; Sutter G
    Adv Virus Res; 2017; 97():187-243. PubMed ID: 28057259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical development of Modified Vaccinia virus Ankara vaccines.
    Gilbert SC
    Vaccine; 2013 Sep; 31(39):4241-6. PubMed ID: 23523410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chikungunya Virus Vaccines: Viral Vector-Based Approaches.
    Ramsauer K; Tangy F
    J Infect Dis; 2016 Dec; 214(suppl 5):S500-S505. PubMed ID: 27920181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poxviral promoters for improving the immunogenicity of MVA delivered vaccines.
    Alharbi NK
    Hum Vaccin Immunother; 2019; 15(1):203-209. PubMed ID: 30148692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to the development of virus vaccines for veterinary use.
    Yamanouchi K; Barrett T; Kai C
    Rev Sci Tech; 1998 Dec; 17(3):641-53. PubMed ID: 9850535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines.
    Prow NA; Jimenez Martinez R; Hayball JD; Howley PM; Suhrbier A
    Expert Rev Vaccines; 2018 Oct; 17(10):925-934. PubMed ID: 30300041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
    Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG
    J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications and challenges of multivalent recombinant vaccines.
    Naim HY
    Hum Vaccin Immunother; 2013 Mar; 9(3):457-61. PubMed ID: 23249651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel viral vectors in infectious diseases.
    Humphreys IR; Sebastian S
    Immunology; 2018 Jan; 153(1):1-9. PubMed ID: 28869761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaxvec: The first web-based recombinant vaccine vector database and its data analysis.
    Deng S; Martin C; Patil R; Zhu F; Zhao B; Xiang Z; He Y
    Vaccine; 2015 Nov; 33(48):6938-46. PubMed ID: 26403370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.